Aarti Drugs Q3 Results

  • BSE: 524348
  • NSE: AARTIDRUGS
  • ISIN: INE767A01016
  • Sector: Biotechnology & Drugs
BSE
453.74.70 (1.05%)
Volume5.95 K
Updated: Mon 25 Nov, 2024 | 15:52:55
NSE
453.13.85 (0.86%)
Volume1.36 L
Updated: Mon 25 Nov, 2024 | 15:31:33
Today: 451.55
460.90
52-Wk: 430.00
634.90

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Aarti Drugs Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 605.94641.54-%663.96-%
    Selling/ General/ Admin Expenses Total 25.5525.45-%23.68-%
    Depreciation/ Amortization 12.6612.61-%12.62-%
    Other Operating Expenses Total 105.02110.62-%106.73-%
    Total Operating Expense 548.47577.71-%605.94-%
    Operating Income 57.4763.83-%58.02-%
    Net Income Before Taxes 51.5556.27-%49.68-%
    Net Income 36.6739.60-%36.69-%
    Diluted Normalized EPS 3.994.29-%3.96-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts